Bruce L Miller Selected Research

Mental Disorders (Mental Disorder)

5/2016	The behavioural variant frontotemporal dementia (bvFTD) syndrome in psychiatry.
1/2015	The 5-HTTLPR variant in the serotonin transporter gene modifies degeneration of brain regions important for emotion in behavioral variant frontotemporal dementia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruce L Miller Research Topics

Disease

126	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 07/2002
72	Frontotemporal Dementia (Semantic Dementia) 12/2023 - 11/2003
61	Dementia (Dementias) 04/2024 - 02/2004
60	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 04/2024 - 03/2004
46	Cognitive Dysfunction 03/2024 - 03/2005
34	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 02/2009
29	Atrophy 01/2024 - 05/2006
26	Tauopathies 01/2024 - 06/2002
16	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 12/2023 - 03/2004
15	Corticobasal Degeneration 12/2022 - 06/2008
14	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2023 - 10/2006
12	Primary Progressive Aphasia 01/2021 - 10/2008
9	Inflammation (Inflammations) 01/2024 - 11/2011
9	Disease Progression 01/2022 - 02/2008
8	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2019 - 06/2006
7	Pick Disease of the Brain (Pick's Disease) 12/2022 - 06/2002
7	Parkinson Disease (Parkinson's Disease) 01/2021 - 10/2009
6	Sporadic Creutzfeldt-Jakob Disease 01/2021 - 06/2003
6	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 10/2015 - 02/2004
5	Traumatic Brain Injuries (Traumatic Brain Injury) 04/2024 - 01/2019
5	Sarcoma (Soft Tissue Sarcoma) 04/2014 - 07/2010
4	TDP-43 Proteinopathies 01/2023 - 12/2013
3	Proteostasis Deficiencies 01/2024 - 04/2014
3	Chronic Traumatic Encephalopathy 01/2023 - 01/2020
3	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2022 - 03/2005
3	Amyloid Plaque 05/2021 - 04/2015
3	Amyloidosis 01/2017 - 10/2008
3	Neuroinflammatory Diseases 01/2017 - 09/2011
3	Multiple System Atrophy 12/2013 - 03/2004
2	Craniocerebral Trauma (Head Injury) 11/2023 - 01/2019
2	Schizophrenia (Dementia Praecox) 02/2023 - 01/2018
2	Tuberous Sclerosis (Bourneville's Disease) 01/2023 - 01/2020
2	Neurobehavioral Manifestations 01/2023 - 02/2016
2	Epilepsy (Aura) 01/2023 - 09/2013
2	COVID-19 12/2022 - 01/2021
2	Memory Disorders (Memory Loss) 01/2022 - 01/2018
2	Pathologic Processes 12/2021 - 02/2019
2	Prodromal Symptoms 01/2021 - 02/2015
2	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 12/2019 - 12/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 02/2015
2	Insulin Resistance 01/2018 - 02/2015
2	Seizures (Absence Seizure) 01/2017 - 09/2013

Drug/Important Bio-Agent (IBA)

66	Biomarkers (Surrogate Marker)IBA 01/2024 - 06/2006
58	Amyloid (Amyloid Fibrils)IBA 03/2024 - 10/2008
44	Proteins (Proteins, Gene)FDA Link 01/2024 - 03/2007
34	ProgranulinsIBA 01/2023 - 03/2007
26	DNA-Binding Proteins (DNA Binding Protein)IBA 12/2023 - 06/2008
23	Apolipoproteins E (ApoE)IBA 12/2023 - 05/2006
14	tau Proteins (tau Protein)IBA 03/2024 - 06/2002
13	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2023 - 02/2017
11	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2023 - 05/2010
11	ApolipoproteinsIBA 01/2022 - 05/2006
10	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2021 - 10/2008
7	Amyloid beta-PeptidesIBA 01/2023 - 02/2010
7	UbiquitinIBA 12/2017 - 06/2005
6	TESIBA 04/2024 - 01/2019
6	RNA (Ribonucleic Acid)IBA 11/2023 - 08/2011
6	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 10/2008
5	Butylated Hydroxyanisole (BHA)IBA 01/2024 - 01/2018
5	AntibodiesIBA 01/2023 - 06/2002
5	Apolipoprotein E4IBA 01/2021 - 02/2009
5	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 06/2008
5	PrionsIBA 01/2017 - 07/2006
4	Protein AggregatesIBA 10/2023 - 04/2014
4	Protein Isoforms (Isoforms)IBA 01/2023 - 06/2002
4	LipidsIBA 01/2023 - 01/2019
4	alpha-SynucleinIBA 01/2023 - 03/2004
4	Complement System Proteins (Complement)IBA 02/2022 - 07/2010
4	Prion ProteinsIBA 10/2015 - 02/2004
3	Glial Fibrillary Acidic ProteinIBA 08/2023 - 01/2020
3	Threonine (L-Threonine)FDA Link 01/2023 - 02/2015
3	Memantine (Namenda)FDA Link 01/2022 - 07/2009
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2022 - 04/2010
3	Retinaldehyde (Retinal)IBA 01/2022 - 09/2014
3	FluorineIBA 01/2021 - 01/2020
3	Indicators and Reagents (Reagents)IBA 01/2020 - 12/2016
3	Insulin (Novolin)FDA Link 01/2018 - 02/2014
3	RNA-Binding Protein FUSIBA 05/2013 - 07/2010
2	TabletsIBA 01/2024 - 01/2021
2	Opioid Analgesics (Opioids)IBA 01/2023 - 07/2011
2	Cathepsin DIBA 01/2023 - 07/2015
2	Carrier Proteins (Binding Protein)IBA 01/2023 - 01/2019
2	lysosomal proteinsIBA 01/2023 - 07/2015
2	Peptides (Polypeptides)IBA 12/2021 - 11/2016
2	Levetiracetam (Keppra)FDA LinkGeneric 11/2021 - 09/2013
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 03/2005
2	GranulinsIBA 01/2021 - 06/2015
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 12/2020 - 09/2014
2	EnzymesIBA 12/2019 - 09/2012
2	Neurotransmitter Agents (Neurotransmitter)IBA 10/2019 - 05/2010
2	LigandsIBA 01/2019 - 11/2018
2	CholesterolIBA 01/2019 - 01/2019
2	Biological FactorsIBA 01/2019 - 01/2006
2	HDL LipoproteinsIBA 01/2019 - 07/2006
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018 - 09/2012
2	AD 20 (AD-20)IBA 01/2018 - 02/2015
2	ChemokinesIBA 03/2017 - 01/2016
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2017 - 12/2016

Therapy/Procedure

23	Therapeutics 01/2024 - 11/2007
2	Long-Term Care 01/2021 - 11/2003